Magnetic resonance imaging techniques for monitoring changes in tumor oxygenation and blood flow.
暂无分享,去创建一个
J R Griffiths | F A Howe | F. Howe | J. Griffiths | S. Robinson | M. Stubbs | S P Robinson | M Stubbs | L M Rodrigues | L. Rodrigues
[1] B. Teicher,et al. Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells. , 1981, Cancer research.
[2] J. Collier,et al. A therapeutic benefit from combining normobaric carbogen or oxygen with nicotinamide in fractionated X-ray treatments. , 1991, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[3] C. Song,et al. Quantitative study of vascularity in Walker carcinoma 256. , 1971, Cancer research.
[4] C. Grau,et al. Relationship between tumour oxygenation, bioenergetic status and radiobiological hypoxia in an experimental model. , 1995, Acta oncologica.
[5] P. Vaupel,et al. Tumor tissue oxygenation as evaluated by computerized-pO2-histography. , 1990, International journal of radiation oncology, biology, physics.
[6] B Vojnovic,et al. Tumour radiosensitization by high-oxygen-content gases: influence of the carbon dioxide content of the inspired gas on PO2, microcirculatory function and radiosensitivity. , 1998, International journal of radiation oncology, biology, physics.
[7] U. Carl,et al. Effect of normobaric oxygen on tumor radiosensitivity: fractionated studies. , 1990, International journal of radiation oncology, biology, physics.
[8] V. Kuperman,et al. Changes in T2*‐Weighted Images During Hyperoxia Differentiate Tumors from Normal Tissue , 1995, Magnetic resonance in medicine.
[9] P. Okunieff,et al. Effects of Oxygen on the Metabolism of Murine Tumors Using in Vivo Phosphorus‐31 NMR , 1987, American journal of clinical oncology.
[10] F. Hall. Minimal utilizable oxygen and the oxygen dissociation curve of blood of rodents. , 1966, Journal of applied physiology.
[11] R K Jain,et al. Determinants of tumor blood flow: a review. , 1988, Cancer research.
[12] A. Rojas. Radiosensitization with normobaric oxygen and carbogen. , 1991, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[13] J H Duyn,et al. Inflow versus deoxyhemoglobin effects in bold functional MRI using gradient echoes at 1.5 T , 1994, NMR in biomedicine.
[14] J C Gore,et al. Physiologic basis for BOLD MR signal changes due to hypoxia/hyperoxia: Separation of blood volume and magnetic susceptibility effects , 1997, Magnetic resonance in medicine.
[15] M. Dewhirst,et al. The mechanisms by which hyperbaric oxygen and carbogen improve tumour oxygenation. , 1995, British Journal of Cancer.
[16] Ravi S. Menon,et al. Functional brain mapping by blood oxygenation level-dependent contrast magnetic resonance imaging. A comparison of signal characteristics with a biophysical model. , 1993, Biophysical journal.
[17] M. Horsman,et al. Further evaluation of nicotinamide and carbogen as a strategy to reoxygenate hypoxic cells in vivo: importance of nicotinamide dose and pre-irradiation breathing time. , 1993, British Journal of Cancer.
[18] G. Tozer,et al. Inhibition of nitric oxide synthase induces a selective reduction in tumor blood flow that is reversible with L-arginine. , 1997, Cancer research.
[19] R. Maxwell,et al. The effect of hypoxia and hyperoxia on nucleoside triphosphate/inorganic phosphate, pO2 and radiation response in an experimental tumour model. , 1997, British Journal of Cancer.
[20] SJ Falk,et al. The influence of carbogen breathing on tumour tissue oxygenation in man evaluated by computerised p02 histography. , 1992, British journal of cancer.
[21] D. Ballon,et al. Changes in radiation sensitization induced by Fluosol-DA as measured by 31P nuclear magnetic resonance spectroscopy. , 1990, Cancer research.
[22] I. Hart,et al. Inhibitors of nitric oxide synthase selectively reduce flow in tumour‐associated neovasculature , 1992, British journal of pharmacology.
[23] L. H. Gray,et al. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. , 1953, The British journal of radiology.
[24] C. Grau,et al. Improving the radiation response in a C3H mouse mammary carcinoma by normobaric oxygen or carbogen breathing. , 1992, International journal of radiation oncology, biology, physics.
[25] R. Turner,et al. Functional mapping of the human visual cortex at 4 and 1.5 tesla using deoxygenation contrast EPI , 1993, Magnetic resonance in medicine.
[26] G. Adams,et al. Manipulation and exploitation of the tumour environment for therapeutic benefit. , 1994, International journal of radiation biology.
[27] L. Schiffer,et al. Effect of dexamethasone on vascular function in RIF-1 tumors. , 1986, Cancer research.
[28] H. Al-Hallaq,et al. Spectroscopic imaging of the water resonance with short repetition time to study tumor response to hyperoxia , 1997, Magnetic resonance in medicine.
[29] C. Song,et al. Increase in pO2 and radiosensitivity of tumors by Fluosol-DA (20%) and carbogen. , 1986, Cancer research.
[30] L Weissfloch,et al. Oxygen-induced MR signal changes in murine tumors. , 1998, Magnetic resonance imaging.
[31] J R Griffiths,et al. The response of human tumors to carbogen breathing, monitored by Gradient-Recalled Echo Magnetic Resonance Imaging. , 1997, International journal of radiation oncology, biology, physics.
[32] F. Howe,et al. The response to carbogen breathing in experimental tumour models monitored by gradient-recalled echo magnetic resonance imaging. , 1997, British Journal of Cancer.
[33] L. H. Gray,et al. Determination of the oxyhaemoglobin dissociation curves for mouse and rat blood , 1964, The Journal of physiology.
[34] F. Howe,et al. Modification of Tumour Perfusion and Oxygenation Monitored by Gradient Recalled Echo MRI and 31P MRS , 1996, NMR in biomedicine.
[35] S. Vijayakumar,et al. Effects of hyperoxia on T 2* and resonance frequency weighted magnetic resonance images of rodent tumours , 1994, NMR in biomedicine.
[36] F. Howe,et al. Noninvasive monitoring of carbogen-induced changes in tumor blood flow and oxygenation by functional magnetic resonance imaging. , 1995, International journal of radiation oncology, biology, physics.
[37] A. D. de Crespigny,et al. MR imaging of blood oxygenation‐dependent changes in focal renal ischemia and transplanted liver tumor in rat , 1993, Journal of magnetic resonance imaging : JMRI.
[38] C. Thiemermann,et al. Modification of energy metabolism and radiation response of a murine tumour by changes in nitric oxide availability. , 1993, Biochemical and biophysical research communications.
[39] J. Griffiths,et al. Carbogen breathing increases 5-fluorouracil uptake and cytotoxicity in hypoxic murine RIF-1 tumors: a magnetic resonance study in vivo. , 1998, Cancer research.
[40] R. Turner,et al. Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[41] R R Edelman,et al. Effect of oxygen inhalation on relaxation times in various tissues , 1997, Journal of magnetic resonance imaging : JMRI.
[42] H. Merkle,et al. Relationships Among Lactate Concentration, Blood Flow and Histopathologic Profiles in Rat C6 Glioma , 1996, NMR in biomedicine.
[43] S. Ogawa,et al. Oxygenation‐sensitive contrast in magnetic resonance image of rodent brain at high magnetic fields , 1990, Magnetic resonance in medicine.
[44] M. Dewhirst,et al. Nitric oxide synthase inhibition irreversibly decreases perfusion in the R3230Ac rat mammary adenocarcinoma. , 1995, British Journal of Cancer.
[45] J. Griffiths,et al. In vivo detection of ifosfamide by 31P-MRS in rat tumours: increased uptake and cytotoxicity induced by carbogen breathing in GH3 prolactinomas. , 1997, British Journal of Cancer.
[46] M. Horsman,et al. Nicotinamide, Fluosol DA and Carbogen: a strategy to reoxygenate acutely and chronically hypoxic cells in vivo. , 1991, British Journal of Cancer.